BBH

VanEck Vectors Biotech ETF
CLOSING PRICECHANGE (%)VOLUME
$133.57-0.06 (-0.05%)8.37K
3:59:00 p.m. (ET) 09/22/2017
BZX EXCHANGE CLOSED
LAST TRADECHANGE (%)
---- (--)
BID SIZEBID ($)ASK ($)ASK SIZE
--------
A

77
  • Overview
  • Efficiency
  • Tradability
  • Fit

BBH Fund Description

The VanEck Vectors Biotech ETF tracks a market-cap-weighted index of the 25 largest biotech firms globally.

BBH FactSet Analytics Insight

While the global biotech industry is heavily concentrated in the US, BBH is even more concentrated in a small portfolio of just 25 US-listed companies weighted by capitalization. It also has a flexible definition of biotech, with many of the firms it holds perhaps better classified as pharmaceuticals and medical equipment rather than pure biotech. Despite the fund's conversion to a 1940 Act open-ended structure, diversification requirements have scarcely made BBH a less top-heavy, concentrated fund, with much of its portfolio comprised of a handful of companies. Despite not looking much like the global market, it's a popular fund with investors. Its daily trading volume is high, and its underlying assets are highly liquid. BBH's expense ratio is reasonable for the segment, though perhaps high for a fund that ultimately holds just 25 US-listed firms and ADRs, but tracking is undeniably close.

BBH MSCI ESG Fund metrics Insight

The MSCI ESG Fund Quality Score measures the ability of ETF underlying holdings to manage key medium to long-term risks and opportunities arising from environmental, social, and governance factors, as determined by MSCI ESG Research LLC. As of September 21, 2017 the VanEck Vectors Biotech ETF MSCI ESG Fund Quality Score is 4.41 out of 10.

The fund’s Peer Rank reflects the ranking of a fund’s MSCI ESG Fund Quality Score against the scores of other funds within the same peer group, as defined by the Thomson Reuters Lipper Global Classification. BBH ranks in the 28th percentile within its peer group and in the 18th percentile within the global universe of all funds in MSCI ESG Fund Metrics coverage.

  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max
COMPARE
RESET
Select ETFs to compare their performance:

BBH Top 10 Countries View All

BBH Top 10 Sectors

BBH Top 10 Holdings View All

BBH Summary Data

12/20/11
Open-Ended Fund
0.35%
$712.06 M
$3.31 M
0.08%

BBH Portfolio Data

$58.33 B
28.92
4.41
0.24%
12/18/17
25

BBH Index Data

MVIS US Listed Biotech 25 Index
Market Cap
Market Cap
Thomson Reuters Global Biotechnology & Medical Research

Related ETFs to BBH

ARKG
Total Return
  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max

BBH Portfolio Management

0.35%
-0.32%
-0.24%
-0.41%

BBH Tax Exposures

20.00% / 39.60%
--
Qualified dividends
No

BBH Fund Structure

Open-Ended Fund
No
Yes
100% / 0%%
N/A
N/A
Low
Daily
Bats Book Viewer
TOP OF BOOK
SHARES/SIZEPRICE
ASKS----
----
----
----
----
BIDS----
----
----
----
----
LAST 10 TRADES
TIMEPRICESHARES
15:59:58133.57100
14:44:49133.431
------
------
------
------
------
------
------
------
Bats BZX Real-time Quote - 23:59:59
Daily Spread
Premium/Discount
Volume

BBH FactSet Analytics Block Liquidity

As of 09/22/17
5
4
3
2
1

This measurement shows how easy it is to trade a $1 million USD block of BBH. BBH is rated a 5 out of 5.

BBH Tradability

25,136
$3.31 M
16,456
$2.18 M
0.08%
$0.1
-0.00%
0.13% / -0.25%
None
100.00%
50,000
0.33
0.01%
0.23%
1,223
$133.63
5

BBH Performance Statistics

0.94
1.06
1.05
1.06
0.32%
Thomson Reuters Global Biotechnology & Medical Research

BBH MSCI ESG Fund Metrics

4.41 / 10
28.05
17.56
--
50.51%
17.88